LianBio
Open
–
Prev. Close
–
High
–
Low
–
Market Snapshot
$17.14M
-0.2
-0.81
163
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
Recently from Cashu
LianBio Launches Vitaura to Transform Aesthetic Medicine in Italy
LianBio Launches Vitaura: A New Era in Aesthetic Medicine Consolidation LianBio, a prominent player in the healthcare sector, unveils its latest venture, Vitaura, on January 9, 2025. This new consolid…
LianBio Launches Vitaura to Transform Aesthetic Medicine and Address Market Fragmentation
LianBio's Vitaura Sets New Standards in Aesthetic Medicine LianBio launches Vitaura, a consolidation business aimed at revolutionizing the aesthetic medicine and longevity sectors. The initiative emer…
LianBio Launches Vitaura to Transform Italy's Aesthetic Medicine Market
LianBio Expands into Aesthetic Medicine with Launch of Vitaura LianBio announces the launch of Vitaura, a new initiative designed to consolidate the aesthetic medicine, surgery, and longevity sectors…